Annual ROE
-36.89%
+14.47%+28.17%
December 31, 2023
Summary
- As of February 12, 2025, QNCX annual return on equity is -36.89%, with the most recent change of +14.47% (+28.17%) on December 31, 2023.
- During the last 3 years, QNCX annual ROE has risen by +7.72% (+17.31%).
- QNCX annual ROE is now -161.15% below its all-time high of 60.33%, reached on December 31, 2017.
Performance
QNCX ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-84.83%
-11.40%-15.52%
September 30, 2024
Summary
- As of February 12, 2025, QNCX quarterly return on equity is -84.83%, with the most recent change of -11.40% (-15.52%) on September 30, 2024.
- Over the past year, QNCX quarterly ROE has dropped by -48.47% (-133.31%).
- QNCX quarterly ROE is now -302.75% below its all-time high of 41.84%, reached on March 31, 2019.
Performance
QNCX Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
QNCX ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +28.2% | -133.3% |
| 3 y3 years | +17.3% | -133.3% |
| 5 y5 years | -196.5% | -133.3% |
QNCX ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +51.4% | -173.0% | at low |
| 5 y | 5-year | -15.2% | +51.4% | -173.0% | at low |
| alltime | all time | -161.2% | +51.4% | -302.8% | +10.6% |
Quince Therapeutics ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -84.83%(+15.5%) |
| Jun 2024 | - | -73.43%(+99.6%) |
| Mar 2024 | - | -36.78%(+1.2%) |
| Dec 2023 | -36.89%(-28.2%) | -36.36%(+17.0%) |
| Sep 2023 | - | -31.07%(-3.0%) |
| Jun 2023 | - | -32.02%(-23.0%) |
| Mar 2023 | - | -41.56%(-14.9%) |
| Dec 2022 | -51.36%(-32.3%) | -48.85%(-22.5%) |
| Sep 2022 | - | -63.06%(-11.2%) |
| Jun 2022 | - | -71.03%(+0.3%) |
| Mar 2022 | - | -70.84%(+8.3%) |
| Dec 2021 | -75.85% | -65.44%(+13.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | -57.73%(+9.4%) |
| Jun 2021 | - | -52.76%(+15.1%) |
| Mar 2021 | - | -45.84%(+16.9%) |
| Dec 2020 | -44.61%(+39.3%) | -39.22%(+3.8%) |
| Sep 2020 | - | -37.78%(+10.3%) |
| Jun 2020 | - | -34.24%(+5.4%) |
| Mar 2020 | - | -32.48%(-25.1%) |
| Dec 2019 | -32.02%(-183.7%) | -43.38%(-25.5%) |
| Sep 2019 | - | -58.22%(-38.6%) |
| Jun 2019 | - | -94.87%(-326.7%) |
| Mar 2019 | - | 41.84%(+9.4%) |
| Dec 2018 | 38.24%(-36.6%) | 38.24% |
| Dec 2017 | 60.33% | - |
FAQ
- What is Quince Therapeutics annual return on equity?
- What is the all time high annual ROE for Quince Therapeutics?
- What is Quince Therapeutics annual ROE year-on-year change?
- What is Quince Therapeutics quarterly return on equity?
- What is the all time high quarterly ROE for Quince Therapeutics?
- What is Quince Therapeutics quarterly ROE year-on-year change?
What is Quince Therapeutics annual return on equity?
The current annual ROE of QNCX is -36.89%
What is the all time high annual ROE for Quince Therapeutics?
Quince Therapeutics all-time high annual return on equity is 60.33%
What is Quince Therapeutics annual ROE year-on-year change?
Over the past year, QNCX annual return on equity has changed by +14.47% (+28.17%)
What is Quince Therapeutics quarterly return on equity?
The current quarterly ROE of QNCX is -84.83%
What is the all time high quarterly ROE for Quince Therapeutics?
Quince Therapeutics all-time high quarterly return on equity is 41.84%
What is Quince Therapeutics quarterly ROE year-on-year change?
Over the past year, QNCX quarterly return on equity has changed by -48.47% (-133.31%)